Biomarker: F077-IgE Beta Lactoglobulin

Overview

F077-IgE Beta Lactoglobulin measures immunoglobulin E (IgE) antibodies directed against beta-lactoglobulin, a major whey protein in cow’s milk and a recognized milk allergen. Beta-lactoglobulin-specific IgE indicates immune sensitization to this protein, but a positive result does not by itself establish clinical cow’s milk allergy. Higher levels may support the possibility of an IgE-mediated reaction when consistent symptoms occur after milk exposure, while a low or undetectable level makes sensitization to beta-lactoglobulin less likely but does not exclude allergy to other milk proteins. The test is clinically useful as part of an allergy-focused evaluation and may help identify the specific milk component involved, but diagnosis may require supervised oral food challenge.

Clinical Use Cases

Supporting evaluation of suspected IgE-mediated cow’s milk allergy when the clinical history indicates milk as a possible trigger.
Identifying sensitization specifically to beta-lactoglobulin rather than relying only on testing to whole cow’s milk.
Helping characterize milk-allergic patients in clinical research involving milk protein components, processing, or tolerance.
Contributing to assessment of whether symptoms may be related to a whey protein component, alongside clinical history and other testing.
Monitoring allergen-specific IgE over time in selected patients, when clinically indicated. Changes in concentration should not be interpreted alone as proof of allergy resolution or persistence.

Specimen Types

Venous blood, with serum used for quantitative allergen-specific IgE testing.
Plasma may be accepted by some laboratory methods, depending on the assay and laboratory protocol.

Measurement Methods

In vitro serum allergen-specific IgE immunoassay.
Fluorescence enzyme immunoassay, including systems in which beta-lactoglobulin is coupled to a solid-phase allergen matrix and bound IgE is detected with enzyme-labeled anti-human IgE.
Enzyme-linked immunosorbent assay (ELISA) in research settings.
Results are commonly reported in kUA/L or equivalent units and may be categorized into analytical classes. Cutoffs and interpretation ranges vary by method and laboratory.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergy blood test.
Special preparation is usually not required, but patients should follow the ordering clinician’s instructions.
Tell the clinician about all medications and supplements. Some medicines, including antihistamines, may need consideration for allergy testing, although patients should not stop prescribed medicines without medical advice.
The result reflects sensitization and does not measure the severity of a future reaction.
A positive result may occur without symptoms after eating milk. Clinical interpretation requires the timing, reproducibility, and nature of symptoms associated with exposure.
Testing to beta-lactoglobulin does not assess sensitization to all cow’s milk proteins, including casein and alpha-lactalbumin.
Assay-specific reference ranges, detection limits, and reporting units may differ between laboratories.
Skin testing and serum-specific IgE testing may be affected by the test method and allergen preparation; results should not be compared directly across methods without appropriate clinical interpretation.